Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events fda patient reported outcomes pro labeling over last 10 years
… RTI-HS Webinar - Lessons Learned From a Review of FDA PRO Labeling Share on: December 12, 2016 Image Click to … Labeling The last decade has seen an increased focus on patient-centered drug development. Product labeling based on patient-reported outcomes (PRO) endpoints are therefore of special …
… Webinar: Characteristics of Recent PRO Labeling by the FDA and EMA for Oncology Drugs Share on: Wednesday, March 13 … the Recording Trends in EMA and FDA Labeling Based on Patient-Reported Outcomes (PROs) A recent review of labels from drugs …
… Trends in the Inclusion of Patient Reported Outcomes in Oncology Clinical Trials Margaret … assessment of PROs. Over the last five years, the US FDA has advocated for including patients’ voice in drug …
… 2020 FDA Patient-Reported Outcomes Guidance Draft On August 31, 2020, the FDA released …
… New FDA Draft Guidance For Evaluating Patient-Reported Outcomes in Clinical Trials Share on: September 3, …
… Patient-Centered Outcomes Assessment Whether your goal is to support product … of clinical outcome assessments (COAs), including patient-reported outcome (PRO), observer-reported outcome (ObsRO), clinician-reported …
… regulatory negotiations. Our team has negotiated with the FDA’s Clinical Outcome Assessments (COA) team and a wide … acceptable to the FDA following the release of the FDA’s PRO Guidance. To support these efforts, we have developed … clients to FDA meetings in support of their proposed labeling claims. Our experts, particularly those based in …
… Analysis of Heterogeneity of Treatment Effects for Patient-Centered Outcomes Let us help you understand your … - Identify and define unique responders - Identify patient-reported outcome items/subscales - Power Phase II and recruit … claims - Inform safety studies and reduce risks of adverse events Abandoned Drugs - Rescue, repurpose, or resurrect …
… New Patient-Reported Outcomes Diary for Rare Acromegaly Disorder Share on: … drug development. The US Food and Drug Administration (FDA) strongly encourages the use of PROs in clinical trials …
… ISPOR Advanced Patient-Reported Outcomes Course- Virtual Share on: Wednesday, June 8 - … discussion of the steps needed to successfully implement PRO measurement within the drug development program to …